Annual report pursuant to Section 13 and 15(d)

Acquisition - Purchase price allocation (Details)

v3.22.1
Acquisition - Purchase price allocation (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Oct. 21, 2021
Dec. 18, 2020
Business Acquisition [Line Items]        
Contingent Consideration $ 0 $ 0    
Panoptes        
Business Acquisition [Line Items]        
Current Assets       $ 410,863
In-Process R&D       5,624,100
Goodwill       1,958,711
Property, Plant and Equipment       2,042
Accounts Payable and Other Liabilities       (87,777)
Deferred Tax Liability       (351,507)
Contingent Consideration       (3,632,950)
Assumed Liabilities       (312,852)
Total Purchase Price       3,610,630
Cash       333,860
Receivables       73,368
Prepaid expenses       $ 3,635
Net losses of acquiree from the acquisition date   34,000.000    
Acquisition-related costs 50,000.000 $ 414,000    
Bayon        
Business Acquisition [Line Items]        
Current Assets     $ 5,290  
In-Process R&D     761,000  
Goodwill     1,013,627  
Accounts Payable and Other Liabilities     (36,525)  
Deferred Tax Liability     (190,291)  
Contingent Consideration     (1,388,101)  
Total Purchase Price     $ 165,000  
Cash 3,910      
Receivables 1,380      
Net losses of acquiree from the acquisition date 128,000      
Acquisition-related costs $ 90,000.000